Triple combination pill reduces recurrent stroke risk
Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of another stroke in patients with intracerebral hemorrhage and high blood...
View ArticleLay health workers improve blood pressure control in rural Africa
In rural regions of Africa, high blood pressure often goes untreated because health centers are far away and there is a shortage of health professionals.
View ArticleCan natural supplements backfire? Review explains how and why
A new review uncovers how common natural supplements can both protect and endanger health, depending on dose, duration, and delivery—and points to next-gen technologies as the key to unlocking their...
View ArticleBlood pressure medication amlodipine shows promise in treating ADHD symptoms
Repurposing amlodipine, a commonly used blood pressure medicine, could help manage attention-deficit/ hyperactivity disorder (ADHD) symptoms, according to an international study involving the...
View ArticleBlood pressure control improved with dual medication pills in India
Medication variations that combined two of three different blood pressure-lowering medications into a single pill worked equally well in reducing blood pressure and were safe among adults in India,...
View ArticleTriple-pill combination GMRx2 outperforms standard care in lowering blood...
New research shows that a treatment plan based on novel combination of low doses of three anti-hypertensive drugs in a single pill - known as GMRx2 - was superior to a high-quality standard care...
View ArticleQUADRO trial demonstrates superior blood pressure control with four-in-one...
A single-pill combination of four blood-pressure (BP)-lowering medications was significantly more effective than a combination of three medications, according to late-breaking research presented in a...
View ArticleLow-dose triple-pill combination outperforms standard care for blood pressure...
A low-dose triple single-pill combination-based protocol achieved better blood pressure (BP) control than a standard-care protocol in Black African Nigerian adults with uncontrolled hypertension,...
View ArticleStudy shows promise of zilebesiran injection in reducing systolic blood pressure
A single subcutaneous injection of the investigational drug zilebesiran, when added to existing treatment with a standard antihypertensive medication, reduced systolic blood pressure by between 4 to 12...
View ArticleTeva UK and Closed Loop Medicine announce strategic partnership to advance...
Teva UK Limited and Closed Loop Medicine Ltd have announced a strategic partnership to advance the development of personalised medicine.
View ArticleStudy reassures patients on safety of widely prescribed hypertension drug...
A new paper in the journal Function, published by Oxford Univetrsity Press, finds that a widely prescribed drug for treating hypertension, amlodipine, is not dangerous for patients, despite recent...
View ArticleNew insights into the link between EMFs, calcium and Alzheimer’s disease
For almost a quarter of a century, researchers have been studying and publishing on the effect of calcium on Alzheimer's Disease. Research has led to the development of the calcium hypothesis of...
View ArticleIdentifying and managing drug-drug interactions key to the safe use of...
Researchers compiled evidence-based recommendations in consultation with European and North American clinicians and pharmacologists for recognizing and managing drug-drug interactions with...
View ArticleExploring the potential utility of calcium channel inhibitors in SARS-CoV-2...
In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.
View ArticleIntensive blood-pressure control benefits older hypertensive patients
Aggressive blood pressure treatment in older hypertensive patients lowers the incidence of cardiovascular events compared to standard therapy, without increasing adverse outcomes. That's the finding of...
View ArticleScientists identify new therapeutic targets for SARS-CoV-2
To identify new potential therapeutic targets for SARS-CoV-2, a team of scientists at the New York Genome Center, New York University, and the Icahn School of Medicine at Mount Sinai, performed a...
View ArticleCommon high blood pressure medications do not increase risk of depression
None of the 41 most common high blood pressure medications increased the risk of depression, while nine medications appeared to lower it, according to a study from Denmark, published today in...
View ArticleStrong evidence several FDA approved drugs block SARS-CoV-2 in relevant...
Now, a new study describes how compounds that restore the normal transcriptional conditions following infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be used to reduce...
View ArticleAntihypertensive drug associated with lower risk of gout
Affecting more than 7 million adults in the United States, gout is characterized by a sudden onset of pain, swelling and stiffness in the joints and caused by the formation of urate crystal in small...
View ArticleTwo-drug combinations containing calcium channel blocker significantly lowers BP
In the largest randomized controlled trial of treatment for high blood pressure ever conducted in sub-Saharan Africa, two frontline two-drug combinations that included the long-acting calcium channel...
View Article
![Cloonee, Yandel & ATLAC – Movimiento – Single [iTunes Plus M4A]](http://i.imgur.com/Q8tO40p.jpeg)